Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes

Abstract

Cannabidiol (CBD) and cannabigerol (CBG) are Cannabis sativa terpenophenols. Although CBD’s effectiveness against neurological diseases has already been demonstrated, nothing is known about CBG. Therefore, a comparison of the effects of these compounds was performed in two experimental models mimicking the oxidative stress and neurotoxicity occurring in neurological diseases. Rat astrocytes were exposed to hydrogen peroxide and cell viability, reactive oxygen species production and apoptosis occurrence were investigated. Cortexes were exposed to K+ 60 mM depolarizing stimulus and serotonin (5-HT) turnover, 3-hydroxykinurenine and kynurenic acid levels were measured. A proteomic analysis and bioinformatics and docking studies were performed. Both compounds exerted antioxidant effects in astrocytes and restored the cortex level of 5-HT depleted by neurotoxic stimuli, whereas sole CBD restored the basal levels of 3-hydroxykinurenine and kynurenic acid. CBG was less effective than CBD in restoring the levels of proteins involved in neurotransmitter exocytosis. Docking analyses predicted the inhibitory effects of these compounds towards the neurokinin B receptor. Conclusion: The results in the in vitro system suggest brain non-neuronal cells as a target in the treatment of oxidative conditions, whereas findings in the ex vivo system and docking analyses imply the potential roles of CBD and CBG as neuroprotective agents.

Protective Effects of Cannabidivarin and Cannabigerol on Cells of the Blood–Brain Barrier Under Ischemic Conditions

“…It is likely that these decreases in DNA damage proteins were caused indirectly, possibly because of the overall reductions in cellular damage and inflammation, as well as the known antioxidant properties of CBG that have both been demonstrated in other studies. 20,66 Nevertheless, direct modulation of these proteins should not be ruled out particularly as PPAR-c, a known target for phytocannabinoids, has been implicated in ATM signaling and the DDR. 67 Pretreatment with CBDV significantly increased expression of the majority of DNA damage proteins in astrocytes and exhibited a trend for increasing p21.…”

The Effect of Cannabidiol on UV-Induced Changes in Intracellular Signaling of 3D-Cultured Skin Keratinocytes

“…The formation of the CBD-Keap1 adduct significantly contributes to Nrf2/ARE activation, which stimulates the antioxidant system. Proteomic analysis of its effect on cells also shows that CBD strongly activates the Nrf2/ARE pathway by interacting with the Nrf2 nuclear inhibitor Bach1 [ 10 , 50 ]. Changes in the structure of Bach1 reduce its possibility to compete with Nrf2 in DNA-binding, favoring the increased biosynthesis of cytoprotective proteins, including antioxidants [ 51 ].…”

Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders

“…In studies evaluating CBD effects in astrocytes, GFAP and S100β are the most commonly used astroglial markers. di Giacomo et al (2020) showed that astrocytes treated for 48 h with 1 μM of CBD present increased cell proliferation. The same concentration of CBD protected astrocytes from oxidative damage and apoptosis after exposure to hydrogen peroxide in vitro .…”